Global Respiratory Syncytial Virus Markets, 2017-2020 & 2021-2027 - Increasing Disease Burden / Advent of Targeted Therapies / High Cost of Disease Management
31. August 2021 07:13 ET
|
Research and Markets
Dublin, Aug. 31, 2021 (GLOBE NEWSWIRE) -- The "Global Respiratory Syncytial Virus Market Size and Epidemiology (8MM), By Drug Type (Synagis, Other), By Dosage Form (Oral, Other), By Treatment Type...
Global Respiratory Syncytial Virus (RSV) Therapeutics Market Report 2021-2027: U.S. Market is Estimated at $360.6 Million, While China is Forecast to Grow at 9.7% CAGR
20. April 2021 06:53 ET
|
Research and Markets
Dublin, April 20, 2021 (GLOBE NEWSWIRE) -- The "Respiratory Syncytial Virus (RSV) Therapeutics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering....